Novo Nordisk Lawsuit 2026, 3,191 Ozempic Cases Pending, No Settlement Yet—Bellwether Trials Start Soon, Potential $2 Billion Liability
Novo Nordisk faces 3,191 active lawsuits as of February 2026 in federal multidistrict litigation over Ozempic, Wegovy, and Rybelsus causing severe side effects including gastroparesis, vision loss (NAION), and bowel injuries. No settlement exists yet, but bellwether trials expected to begin in early 2026 could determine compensation for thousands of injured patients, with legal analysts…
